The ZNF227 antibody is a polyclonal immunoglobulin (IgG) designed to detect the Zinc Finger Protein 227 (ZNF227), a transcription factor involved in gene regulation. It is widely used in biomedical research for applications such as immunohistochemistry (IHC), western blotting (WB), and immunoprecipitation (IP). The antibody targets epitopes in the N-terminal or internal regions of the ZNF227 protein, with molecular weight approximately 92,033 Da .
ZNF227 belongs to the krueppel C2H2-type zinc-finger protein family, functioning as a transcriptional regulator. Its gene (ENSG00000131115) encodes a protein with nucleic acid-binding and DNA-specific transcription factor activity . ZNF227 is expressed in the nucleus and plays roles in pathways like RNA polymerase II transcription initiation .
The antibody binds to conserved regions of ZNF227, enabling detection in human tissues. For example:
N-terminal epitope: Covers amino acids 1–30, ensuring specificity for full-length ZNF227 isoforms .
Internal epitope: Recognizes a sequence within the protein’s core, useful for detecting truncated variants .
The antibody undergoes rigorous validation:
Western Blot: Tested with Jurkat cell lysates and recombinant ZNF227 protein .
IHC: Cross-checked with RNA expression data to confirm specificity .
Blocking Peptide Competition: Demonstrates epitope-specific binding .
ZNF227 is overexpressed in multiple cancers, including breast, lung, and colorectal tumors, as shown by Human Protein Atlas data . Its expression correlates with transcriptional activation of oncogenic pathways .
Recent studies highlight the importance of validating antibody specificity. Recombinant antibodies, including anti-ZNF227, outperform traditional polyclonal and monoclonal antibodies in terms of lot-to-lot consistency .
ZNF227 (Zinc Finger Protein 227) is a protein-coding gene that functions as a candidate transcription factor. Among its related pathways is Gene Expression, and its GO annotations include nucleic acid binding and transcription factor activity with sequence-specific DNA binding capabilities . ZNF227 is likely involved in transcriptional regulation processes, similar to other members of the zinc finger protein family. ZNF229 has been identified as an important paralog of this gene .
ZNF227 belongs to the broader family of zinc finger proteins, which often contain C2H2 zinc finger motifs and function as components in various transcriptional regulatory complexes. While specific ZNF227 functions are still being elucidated, research on related zinc finger proteins suggests potential roles in chromatin remodeling and transcriptional control .
Based on current research resources, polyclonal antibodies against ZNF227 are predominantly available. The most characterized include:
| Antibody Type | Host Species | Clonality | Conjugation | Purification Method | Storage Recommendations |
|---|---|---|---|---|---|
| ZNF227 Antibody | Rabbit | Polyclonal | Unconjugated | Affinity chromatography | -20°C in liquid form |
The immunogen typically used for these antibodies is a synthesized peptide derived from human ZNF227 (UniProt ID: Q86WZ6), corresponding to amino acid residues N199-P249 . This specific epitope region ensures detection of endogenous levels of total ZNF227 protein in experimental applications .
ZNF227 antibodies have been validated for several experimental applications:
| Application | Validated | Recommended Dilution | Notes |
|---|---|---|---|
| Western Blot (WB) | Yes | 1:500-1:2000 | Detects endogenous ZNF227 |
| Immunohistochemistry-Paraffin (IHC-p) | Yes | 1:100-300 | For FFPE tissue sections |
| Immunocytochemistry (ICC) | Yes | Experimentally determined | For cultured cells |
| ELISA | Partial | 1:40000 | Limited validation data |
It is important to note that optimal working dilutions should be determined experimentally by each investigator based on specific sample types and experimental conditions . The antibody has demonstrated reactivity against human and mouse species , but validation in other organisms may require additional testing.
When designing experiments with ZNF227 antibodies, consider these methodological recommendations:
For Western Blot:
Start with recommended dilution range (1:500-1:2000) and optimize based on signal strength
Use PVDF membrane for optimal protein binding
Include appropriate positive control (human or mouse cell lysates known to express ZNF227)
Block with 5% non-fat milk or BSA in TBST
Incubate primary antibody overnight at 4°C for optimal binding
For IHC-p:
Begin with 1:100-300 dilution range and titrate as needed
Antigen retrieval methods should be optimized (typically heat-induced epitope retrieval in citrate buffer pH 6.0)
Include appropriate negative controls (omitting primary antibody)
Consider counterstaining to provide cellular context
The antibody is supplied in PBS with 50% glycerol and 0.02% sodium azide at pH 7.4 , which should be considered when designing blocking and washing conditions to minimize background.
For rigorous scientific investigation, the following controls should be implemented:
Positive Controls: Lysates or tissues known to express ZNF227 (based on available data, human cell lines are appropriate)
Negative Controls:
Primary antibody omission
Samples from ZNF227 knockout models (if available)
Pre-absorption of antibody with immunizing peptide
Loading Controls: For Western blots, include housekeeping proteins (GAPDH, β-actin) to normalize expression
Specificity Validation: Consider performing siRNA knockdown of ZNF227 to confirm antibody specificity
These controls help distinguish specific signal from background and ensure experimental validity, particularly important when investigating a transcription factor with potential family member cross-reactivity.
| Issue | Potential Causes | Troubleshooting Approaches |
|---|---|---|
| No signal | Insufficient protein | Increase sample loading; confirm ZNF227 expression in sample |
| Improper antibody dilution | Titrate antibody concentration | |
| Ineffective transfer (WB) | Optimize transfer conditions; confirm with Ponceau staining | |
| Multiple bands | Cross-reactivity | Validate with knockout/knockdown controls |
| Post-translational modifications | Consider phosphatase treatment to confirm | |
| Alternative isoforms | Compare to known molecular weights of isoforms | |
| High background | Insufficient blocking | Extend blocking time; try alternative blocking reagents |
| Excessive antibody | Further dilute primary or secondary antibody |
For persistent issues with ZNF227 antibody applications, researchers should consider that ZNF227 has multiple potential isoforms. The antibody is raised against a specific epitope (N199-P249) , which may not be present in all isoforms or may be masked under certain experimental conditions.
ZNF227 belongs to the zinc finger protein family, many members of which function as transcription factors with sequence-specific DNA binding capabilities. While specific ZNF227 functions are still being characterized, research on related zinc finger proteins provides context:
Structural Similarities: Like other family members, ZNF227 likely contains C2H2 zinc finger motifs that mediate DNA binding
Transcriptional Regulation: ZNF proteins can function as:
Transcriptional activators
Transcriptional repressors
Components of chromatin remodeling complexes
Evolutionary Conservation: ZNF227 gene is present across mammalian species, indicating a potentially conserved function
Researchers investigating ZNF227 should consider the established mechanisms of other zinc finger proteins, particularly ZNF229 (an important paralog) , while recognizing that each family member has unique biological functions.
Current research with ZNF227 antibodies faces several limitations:
Limited Validation Data: While the antibody detects endogenous levels of ZNF227, comprehensive validation across diverse applications and conditions remains limited
Isoform Specificity: The presence of multiple ZNF227 isoforms (as seen in the Cape elephant shrew with isoforms X1 and X2) suggests human ZNF227 may also have multiple isoforms, potentially with different functions
Cross-Reactivity Concerns: The antibody's specificity against other zinc finger proteins requires rigorous validation
To address these limitations, researchers should:
Conduct systematic validation with knockout/knockdown controls
Compare multiple antibodies targeting different epitopes when possible
Include mass spectrometry analysis to confirm target identity
Pair antibody-based approaches with orthogonal techniques (e.g., RNA analysis)
For successful co-immunoprecipitation (Co-IP) studies investigating ZNF227 protein interactions:
Buffer Optimization: Use gentle lysis buffers (containing 0.5% NP-40 or 1% Triton X-100) to preserve protein complexes
Antibody Selection: The polyclonal nature of available ZNF227 antibodies provides advantages for Co-IP by recognizing multiple epitopes
Protocol Recommendations:
Pre-clear lysates with protein A/G beads
Incubate antibody with lysate overnight at 4°C
Include appropriate negative controls (IgG from same species)
Elute under non-denaturing conditions if subsequent activity assays are planned
Validation Steps:
Confirm successful IP by Western blot for ZNF227
Analyze co-precipitated proteins by mass spectrometry or Western blot for suspected interactors
This approach can help identify novel ZNF227 binding partners, potentially illuminating its role in transcriptional regulation complexes.
Given ZNF227's likely function as a transcription factor, ChIP experiments can provide valuable insights into its genomic binding sites. For optimal ChIP results:
Crosslinking Optimization:
Test different formaldehyde concentrations (0.5-1%) and times (10-15 minutes)
For potential indirect DNA interactions, consider dual crosslinking with DSG followed by formaldehyde
Sonication Parameters:
Optimize to achieve DNA fragments of 200-500 bp
Verify fragmentation efficiency by agarose gel electrophoresis
Antibody Considerations:
Current ZNF227 antibodies are polyclonal, which can increase ChIP efficiency but may introduce variability
Use 2-5 μg antibody per ChIP reaction
Include appropriate controls (IgG, input)
Data Analysis:
Perform qPCR for suspected target genes before proceeding to ChIP-seq
For ChIP-seq analysis, include appropriate bioinformatic approaches to identify enriched motifs
Through careful experimental design and methodological optimization, researchers can generate valuable insights into ZNF227's genomic targets and transcriptional regulatory networks.